Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

NIH Grants & Funding for Neutropenia | Kisho | Kisho

Back to Neutropenia

Neutropenia — NIH Grants & Funding

Active and recent NIH-funded research on Neutropenia. Data from NIH RePORTER, last 36 months.

MONDO:0001475

NIH-funded research on Neutropenia

active grants

institutions

researchers

new in last 12 mo.

$28.3M in NIH funding over the last 36 months. Data from NIH RePORTER.

I'm looking for:

Or filter by research focus

Only show active grants

Basic Science(12)

Basic ScienceZIACompleted

Control Of G Protein Signaling: Role Of The RGSs

KEHRL, JOHN·NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

$1,214,536 (FY2022)

Neutropenia — NIH Grants & Funding

Basic Science(12)

Control Of G Protein Signaling: Role Of The RGSs

Protective role of Endothelial Receptor Interacting Protein Kinase 3 (RIPK3) in acute lung injury

Defining the role of PSTPIP2 in neutrophil biology

Cellular Models of PAH-Associated Molecular Defects as a Tool for Identifying New Therapeutic Targets

Pathobiology of VPS45 severe congenital neutropenia

Mechanisms of granulocyte homeostasis

Identification of new genetic causes of congenital neutropenia

The role of Septin6 Group in Murine and Human Hematopoiesis

Regulation of neutrophil death by GSDMD in Candida albicans infection

Mechanistic links between mutations in the CLPB gene and congenital neutropenia

Translational(5)

Bcl-2 and Mcl-1 inhibition for induction of hematopoietic chimerism and renal allograft tolerance without myelosuppression in nonhuman primates

Stimulant for stem cell expansion in vivo to speed recovery of neutropenia secondary to chemotherapy and stem cell transplant

Preclinical development of a nuclear-targeting biologic that safely increases stem cell expansion in vivo to accelerate recovery from neutropenia after chemotherapy and bone marrow transplant

Gene Editing vs Neutrophil Elastase Inhibitors for Treatment of ELANE Associated Neutropenia

Preclinical development of a nuclear-targeting biologic that safely increases stem cell expansion in vivo to accelerate recovery from neutropenia after chemotherapy and bone marrow transplant

Clinical(4)

Extending neutrophil survival in neutropenia-related pneumonia

Enhancing neutrophil function in neutropenia-related pneumonia

Mechanisms of Impaired Granulopoiesis Due to CLPB Mutations

Mechanisms of Resistance and Therapeutic Targets in T-LGL Leukemia

Epi / Nat. History(1)

Severe Chronic Neutropenia International Registry

Gene/Cell Therapy(1)

Gene editing ELANE to understand and treat severe congenital neutropenia

Medical Device(1)

Reducing the incidence of febrile neutropenia in cancer patients treated with chemotherapy with PointCheck: a portable non-invasive neutropenia analyzer

Other(1)

Understanding Cardiac Mitochondrial Quality Control Through the Lens of Barth Syndrome